Sharon Walmsley

23.0k total citations · 4 hit papers
331 papers, 10.8k citations indexed

About

Sharon Walmsley is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Sharon Walmsley has authored 331 papers receiving a total of 10.8k indexed citations (citations by other indexed papers that have themselves been cited), including 209 papers in Infectious Diseases, 137 papers in Epidemiology and 125 papers in Virology. Recurrent topics in Sharon Walmsley's work include HIV/AIDS Research and Interventions (134 papers), HIV Research and Treatment (118 papers) and HIV/AIDS drug development and treatment (107 papers). Sharon Walmsley is often cited by papers focused on HIV/AIDS Research and Interventions (134 papers), HIV Research and Treatment (118 papers) and HIV/AIDS drug development and treatment (107 papers). Sharon Walmsley collaborates with scholars based in Canada, United States and United Kingdom. Sharon Walmsley's co-authors include Irving E. Salit, Pedro Cahn, Joan Montaner, Janet Raboud, Joseph J. Eron, Mona Loutfy, Marina B. Klein, Anita Rachlis, Margaret Johnson and Richard Lalonde and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Sharon Walmsley

318 papers receiving 10.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antiretroviral Treatment of Adult HIV Infection

2008 832 citations Sharon Walmsley et al. profile →
Enfuvirtide, an HIV-1 Fusion Inhibitor, for Drug-Resistant HIV Infection in North and South America

2003 716 citations Sharon Walmsley et al. profile →
Dolutegravir plus Abacavir–Lamivudine for the Treatment of HIV-1 Infection

2013 593 citations Sharon Walmsley et al. profile →
Lopinavir–Ritonavir versus Nelfinavir for the Initial Treatment of HIV Infection

2002 518 citations Sharon Walmsley et al. profile →

Peers

Countries citing papers authored by Sharon Walmsley

Since Specialization

Citations

This map shows the geographic impact of Sharon Walmsley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon Walmsley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon Walmsley more than expected).

Fields of papers citing papers by Sharon Walmsley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharon Walmsley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon Walmsley. The network helps show where Sharon Walmsley may publish in the future.

Co-authorship network of co-authors of Sharon Walmsley

This figure shows the co-authorship network connecting the top 25 collaborators of Sharon Walmsley. A scholar is included among the top collaborators of Sharon Walmsley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharon Walmsley. Sharon Walmsley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Monkeypox Virus Transcriptional Profiles and Host Responses in Skin Lesion Swabs Among Individuals With Human Immunodeficiency Virus 2025 ·The Journal of Infectious Diseases ·(unknown), Darrell H. S. Tan, Abby Li, (unknown), (unknown), Adrienne K. Chan, Sharon Walmsley, Mary Hummel, (unknown), (unknown), Sharmistha Mishra, (unknown), Robert Kozak	1
2	“They didn't think we'd live this long”: A qualitative exploration of older adults living with HIV perspectives on geriatric care in Ontario 2025 ·HIV Medicine ·Kristina M. Kokorelias, (unknown), Andrew D. Eaton, (unknown), (unknown), Christine Sheppard, (unknown), (unknown), (unknown), Marina B. Wasilewski, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Sharon Walmsley, (unknown)	1
3	Early clinical experience using tecovirimat during the 2022 mpox epidemic in Toronto underscores ongoing clinical equipoise and the need for randomized trials 2025 ·Journal of Antimicrobial Chemotherapy ·(unknown), Sharmistha Mishra, (unknown), Kevin Gough, Charlie Tan, Sharon Walmsley, (unknown), Malika Sharma, Adrienne K Chan, Jerome A. Leis, Myo Minn Oo, Darrell H. S. Tan	1
4	Exploring factors influencing the adoption and use of digital health technology for HIV management among older adults living with HIV: A qualitative study 2025 ·Digital Health ·Kristina M. Kokorelias, (unknown), (unknown), (unknown), (unknown), Andrew D. Eaton, (unknown), Christine Sheppard, Hardeep Singh, (unknown), Marina B. Wasilewski, (unknown), (unknown), (unknown), (unknown), Sharon Walmsley, (unknown)	0
5	Socioculturally Appropriate Internet-Based Geriatric Care Model for Older Adults Living With HIV: Experience-Based Co-Design Approach 2025 ·JMIR Aging ·Kristina M. Kokorelias, Marina B. Wasilewski, (unknown), Andrew D. Eaton, (unknown), (unknown), (unknown), Christine Sheppard, (unknown), Hardeep Singh, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Sharon Walmsley, (unknown)	0
6	Switch to fixed-dose doravirine (100 mg) with islatravir (0·75 mg) once daily in virologically suppressed adults with HIV-1 on antiretroviral therapy: 48-week results of a phase 3, randomised, open-label, non-inferiority trial 2024 ·The Lancet HIV ·Jean‐Michel Molina, Giuliano Rizzardini, Catherine Orrell, (unknown), Alexandra Calmy, Shinichi Oka, Federico Hinestrosa, (unknown), Pablo Tebas, Sharon Walmsley, Anjana Grandhi, Stephanie O. Klopfer, Isaias Noel Gendrano, Karen Eves, (unknown), (unknown), Jason Kim	10
7	“It's like it's the old boys club”—the age‐related experiences of diverse older women living with HIV: A scoping review and consultative exercise 2024 ·HIV Medicine ·Kristina M. Kokorelias, (unknown), (unknown), (unknown), (unknown), Sharon Walmsley, (unknown), Katie Lee, (unknown)	0
8	Exploring the Perspectives of Older Adults Living With HIV on Virtual Care: Qualitative Study 2024 ·JMIR Aging ·Kristina M. Kokorelias, (unknown), (unknown), (unknown), (unknown), Christine Sheppard, Hardeep Singh, Andrew D. Eaton, (unknown), Marina B. Wasilewski, (unknown), (unknown), (unknown), (unknown), (unknown), Sharon Walmsley, (unknown)	2
9	Frequent Disengagement and Subsequent Mortality Among People With HIV and Hepatitis C in Canada: A Prospective Cohort Study 2024 ·Open Forum Infectious Diseases ·Sahar Saeed, (unknown), (unknown), Erica E. M. Moodie, Joseph Cox, Curtis Cooper, M. John Gill, Valérie Martel‐Laferrière, Dimitra Panagiotoglou, Sharon Walmsley, Alexander Wong, Marina B. Klein	3
10	Role of fatty liver in the epidemic of advanced chronic liver disease among people with HIV: protocol for the Canadian LIVEHIV multicentre prospective cohort 2023 ·BMJ Open ·(unknown), Sahar Saeed, (unknown), (unknown), (unknown), Erica E. M. Moodie, Colleen Price, (unknown), Curtis Cooper, Sharon Walmsley, Neora Pick, Melanie C. M. Murray, Joseph Cox, Nadine Kronfli, Cecilia T. Costiniuk, Alexandra de Pokomandy, Jean‐Pierre Routy, Bertrand Lebouché, Marina B. Klein, Giada Sebastiani	4
11	Exploring implementation considerations forgeriatric‐HIVclinics: A secondary analysis from a scoping review onHIVmodels of geriatric care 2023 ·HIV Medicine ·Kristina M. Kokorelias, (unknown), (unknown), Sharon Walmsley, (unknown)	3
12	Activation and gut-homing of peripheral T cells in HIV immunologic non-responders despite long term viral suppression 2021 ·PLoS ONE ·(unknown), Leah Szadkowski, Colin Kovacs, (unknown), (unknown), (unknown), Sanja Huibner, Carolyn L. Cummins, Rupert Kaul, Sharon Walmsley	6
13	Cognitive remediation group therapy compared to mutual aid group therapy for people aging with HIV-associated neurocognitive disorder: randomized, controlled trial 2021 ·Social Work With Groups ·Andrew D. Eaton, Shelley L. Craig, Sean B. Rourke, (unknown), (unknown), Barbara Fallon, Sharon Walmsley	8
14	Cocaine/crack use is not associated with fibrosis progression measured by AST-to-Platelet Ratio Index in HIV-HCV co-infected patients: a cohort study 2017 ·BMC Infectious Diseases ·(unknown), Valérie Martel‐Laferrière, Roy Nitulescu, Joseph Cox, Curtis Cooper, Mark Tyndall, Danielle Rouleau, Sharon Walmsley, (unknown), Marina B. Klein	6
15	HIV-1 Alters Intestinal Expression of Drug Transporters and Metabolic Enzymes: Implications for Antiretroviral Drug Disposition 2016 ·Antimicrobial Agents and Chemotherapy ·Olena Kis, Sumathi Sankaran‐Walters, Md. Tozammel Hoque, Sharon Walmsley, Satya Dandekar, Reina Bendayan	36
16	A Randomized Controlled Pilot Trial of Valacyclovir for Attenuating Inflammation and Immune Activation in HIV/Herpes Simplex Virus 2–Coinfected Adults on Suppressive Antiretroviral Therapy 2013 ·Clinical Infectious Diseases ·Tae Joon Yi, Sharon Walmsley, Leah Szadkowski, Janet Raboud, Nimerta Rajwans, Brett Shannon, Sachin Kumar, Kevin C. Kain, Rupert Kaul, Darrell H. S. Tan	21
17	Comparison of Abacavir/Lamivudine and Tenofovir/Emtricitabine Among Treatment-Naive HIV-Infected Patients Initiating Therapy 2011 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Darrell H. S. Tan, Keith Chan, Janet Raboud, Curtis Cooper, Julio Montaner, Sharon Walmsley, Robert S. Hogg, Marina B. Klein, Nimâ Machouf, Sean B. Rourke, Chris Tsoukas, Mona Loutfy	15
18	A CD4+ Cell Count <200 Cells per Cubic Millimeter at 2 Years After Initiation of Combination Antiretroviral Therapy Is Associated With Increased Mortality in HIV-Infected Individuals With Viral Suppression 2010 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Mona Loutfy, Miguel Genebat, David J. Moore, Janet Raboud, Keith Chan, Tony Antoniou, David J. Milan, (unknown), Marina B. Klein, Curtis Cooper, Nimâ Machouf, Sean B. Rourke, Anita Rachlis, Chris Tsoukas, Julio Montaner, Sharon Walmsley, Marek Smieja, Ahmed M. Bayoumi, Edward J. Mills, Robert S. Hogg	39
19	Opt in or opt out: what is optimal for prenatal screening for HIV infection? 2003 ·PubMed ·Sharon Walmsley	42
20	New-onset diabetes mellitus associated with protease inhibitor therapy in an HIV-positive patient: case report and review. 1999 ·Europe PMC (PubMed Central) ·(unknown), Sharon Walmsley, I. George Fantus	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact